BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21980391)

  • 1. TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.
    Zhang Q; Chen L; Helfand BT; Jang TL; Sharma V; Kozlowski J; Kuzel TM; Zhu LJ; Yang XJ; Javonovic B; Guo Y; Lonning S; Harper J; Teicher BA; Brendler C; Yu N; Catalona WJ; Lee C
    PLoS One; 2011; 6(9):e25168. PubMed ID: 21980391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase and demethylase in human prostate cancer.
    Patra SK; Patra A; Zhao H; Dahiya R
    Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts.
    Pan X; Chen Z; Huang R; Yao Y; Ma G
    PLoS One; 2013; 8(4):e60335. PubMed ID: 23560091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models.
    Lee HR; Hwang KA; Choi KC
    Int J Oncol; 2014 Aug; 45(2):595-602. PubMed ID: 24858230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reciprocal role of prostate cancer on stromal DNA damage.
    Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
    Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
    Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
    Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
    Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal TGF-β signaling induces AR activation in prostate cancer.
    Yang F; Chen Y; Shen T; Guo D; Dakhova O; Ittmann MM; Creighton CJ; Zhang Y; Dang TD; Rowley DR
    Oncotarget; 2014 Nov; 5(21):10854-69. PubMed ID: 25333263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
    Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
    Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aza-2'-deoxycytidine induces human Tenon's capsule fibroblasts differentiation and fibrosis by up-regulating TGF-β type I receptor.
    Fu S; Sun L; Zhang X; Shi H; Xu K; Xiao Y; Ye W
    Exp Eye Res; 2017 Dec; 165():47-58. PubMed ID: 28893564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
    Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
    Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
    Vo BT; Cody B; Cao Y; Khan SA
    Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
    Li T; Huang S; Dong M; Gui Y; Wu D
    Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.